Vestcor Inc
NAGE icon

Vestcor Inc’s Niagen Bioscience NAGE Stock Holding History

Vestcor Inc’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-24,457
Closed -$78K – 1296
2026
Q2 		$78K Hold
24,457
– – ﹤0.01% 1137
2026
Q1 		$108K Hold
24,457
– – ﹤0.01% 1120
2025
Q4 		$156K Hold
24,457
– – ﹤0.01% 1004
2025
Q3 		$228K Buy
+24,457
New +$247K 0.01% 952

Other funds holding NAGE

SteelPeak Wealth
SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return
Tieton Capital Management
Tieton Capital Management Yakima, Washington $336M AUM 34.85% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Vestcor Inc's NAGE Position: Q3 2026 in Review

Vestcor Inc sold out of Niagen Bioscience (NAGE) in Q3 2026, closing a stake of 24,457 shares — an estimated $78K sold.

Vestcor Inc first reported a position in NAGE in Q3 2025 and held it in 4 quarters. The position peaked at $228K in Q3 2025. 80 funds tracked by Wall St. Rank hold NAGE as of Q3 2026.

  • Vestcor Inc reported no remaining Niagen Bioscience position as of Q3 2026 after selling out during the quarter.
  • Vestcor Inc sold 24,457 Niagen Bioscience shares in Q3 2026, an estimated $78K.
  • Vestcor Inc first reported a position in Niagen Bioscience in Q3 2025 and held it in 4 quarters.
  • Vestcor Inc's Niagen Bioscience position peaked at $228K in Q3 2025.
  • 80 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2026.

Based on Vestcor Inc's 13F filing for Q3 2026, filed 12 Nov 2026.